Navigation Links
Allotrope Foundation partners with Osthus Inc. to develop state-of-the-art open framework for laboratory data
Date:9/23/2013

WASHINGTON, Sept. 23, 2013 /PRNewswire-USNewswire/ -- Allotrope Foundation – a consortium of leading pharmaceutical and biotech companies – selected Osthus Inc. as the architect of its much anticipated open framework for laboratory data. The scope of services that Osthus will provide includes consulting services to Allotrope, as well as the design, coding and implementation of the framework.

"During the comprehensive and rigorous RFP process, Osthus Inc. kept impressing us with their innovative ideas and intelligent solutions for realizing the concept of Allotrope's framework," said Gordon Hansen, Vice President, Analytical Development at Boehringer Ingelheim and Chair, Board of Directors at Allotrope. "We are excited about the partnership with Osthus Inc. and working together to build the foundation for the intelligent analytical laboratory."

"We look forward to working with Allotrope's innovative and highly motivated members to create a common framework that will move life science companies and their vendors forward by innovating faster and more cost-effectively, while complying with government requirements more easily," said Dr. Torsten Osthus, President of Osthus Inc., and Managing Director of Osthus GmbH. "Osthus Inc. is all about transforming research complexity into decision-making knowledge and process efficiency. Allotrope's framework is an important stepping-stone designed to facilitate that. We are proud to be part of this project."

At a recent one-week workshop in Washington D.C., the development of the framework got underway, starting with joint design and requirement research.

About Allotrope Foundation:
Allotrope Foundation is an international consortium of pharmaceutical companies that is developing an innovative, open framework for managing analytical data throughout its complete lifecycle using a common set of standard tools. Allotrope aims to make the intelligent analytical laboratory a reality – an automated laboratory where data, methods and hardware components are seamlessly shared between disparate platforms, and where one-click reports can be produced using data generated on any analytical instrument. Allotrope's vision of an intelligent analytical laboratory will be realized through the creation of an open "ecosystem" in collaboration and consultation with vendors and the analytical community.
For further information, see http://www.allotrope.org/, or email info@allotrope.org.

About Osthus:
Osthus is a leading global systems integrator specializing in process and data integration for R&D in life sciences and related industries. Equipped with a unique partner portfolio and interdisciplinary subject matter experts, Osthus offers consulting, integration, development, operations and maintenance services to leading research companies world-wide. 
For further information, see http://osthus.com, or email media@osthus.com.


'/>"/>
SOURCE Allotrope Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Partnerschaft zwischen Allotrope Stiftung und Osthus Inc. zur Entwicklung eines hochmodernen offenen Frameworks für Labordaten
2. Chicago Mayor Rahm Emmanuel and Illinois Governor Patrick Quinn Recognize Brain Research Foundations 60th Anniversary
3. Avon Foundation for Women, NIH, and the Center for Advancing Innovation Launch Start-Up Challenge to Advance Breast Cancer Biomedical Invention
4. The tranSMART Foundation Announces New Version of the tranSMART Open Source Data Sharing Platform for the Life Sciences Community
5. Rhythm Awarded $1.35 Million from The Michael J. Fox Foundation to Advance Clinical Development of RM-131 for Refractory Constipation in Parkinsons Disease
6. Wayne State receives National Science Foundation grant for training future nanoengineers
7. The Galien Foundation Celebrates Biomedical Innovation in Fourth Galien Forum
8. The Sidney Kimmel Foundation for Cancer Research Announces 2013 Grant Recipients
9. OU professor recipient of grant from the Simons Foundation Fellows Program in Theoretical Physics
10. The Research Foundation for The State University of New York Enters Site License Agreement with 2Market Information Inc., Publisher of Technology Transfer Tactics
11. Wysebridge Patent Bar Review Supports the National Foundation for Celiac Awareness (NFCA) During Celiac Awareness Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/9/2017)... 2017  BioTech Holdings announced today identification and ... ProCell stem cell therapy prevents limb loss in ... demonstrated that treatment with ProCell resulted in more ... compared to standard bone marrow stem cell administration.  ... reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... 09, 2017 , ... The Giving Tree Wellness Center announces ... needs of consumers who are incorporating medical marijuana into their wellness and health ... As operators of two successful Valley dispensaries, The Giving Tree’s two founders, Lilach ...
(Date:10/7/2017)... ... October 06, 2017 , ... Phase ... metagenome deconvolution product, featuring the first commercially available Hi-C kit. Researchers can ... Hi-C metagenome deconvolution using their own facilities, supplementing the company’s full-service ProxiMeta ...
Breaking Biology Technology:
(Date:4/5/2017)... SEATTLE , April 5, 2017  The Allen ... the Allen Cell Explorer: a one-of-a-kind portal and dynamic ... large-scale 3D imaging data, the first application of deep ... edited human stem cell lines and a growing suite ... the platform for these and future publicly available resources ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):